174 related articles for article (PubMed ID: 29724995)
1. Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation.
Zhou Q; Eldakhakhny S; Conforti F; Crosbie EJ; Melino G; Sayan BS
Cell Death Dis; 2018 May; 9(5):504. PubMed ID: 29724995
[TBL] [Abstract][Full Text] [Related]
2. PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63.
Conforti F; Yang AL; Piro MC; Mellone M; Terrinoni A; Candi E; Tucci P; Thomas GJ; Knight RA; Melino G; Sayan BS
Oncogene; 2013 Oct; 32(40):4758-65. PubMed ID: 23128396
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.
Yin Y; Kizer NT; Thaker PH; Chiappinelli KB; Trinkaus KM; Goodfellow PJ; Ma L
Int J Mol Sci; 2013 Aug; 14(8):16617-37. PubMed ID: 23941783
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
[TBL] [Abstract][Full Text] [Related]
6. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
8. HOXB9 promotes endometrial cancer progression by targeting E2F3.
Wan J; Liu H; Feng Q; Liu J; Ming L
Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
[TBL] [Abstract][Full Text] [Related]
9. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
[TBL] [Abstract][Full Text] [Related]
10. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
12. Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy.
Li Y; Zhang L; Zhou J; Luo S; Huang R; Zhao C; Diao A
Cell Prolif; 2015 Jun; 48(3):338-47. PubMed ID: 25809873
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
[TBL] [Abstract][Full Text] [Related]
16. ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.
Shan W; Wang C; Zhang Z; Luo X; Ning C; Yu Y; Feng Y; Gu C; Chen X
Tumour Biol; 2015 Mar; 36(3):1529-37. PubMed ID: 25608836
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
Miyamoto T; Kashima H; Yamada Y; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
PLoS One; 2016; 11(5):e0155220. PubMed ID: 27168162
[TBL] [Abstract][Full Text] [Related]
18. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
19. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
[TBL] [Abstract][Full Text] [Related]
20. Expression of DJ-1 in endometrial cancer: close correlation with clinicopathological features and apoptosis.
Shu K; Xiao Z; Long S; Yan J; Yu X; Zhu Q; Mei T
Int J Gynecol Cancer; 2013 Jul; 23(6):1029-35. PubMed ID: 23727824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]